Communicating benefits and risks of medicines

The safer use of medicines depends on everyone’s constant awareness and vigilance – strong communications practice is an important part of that process.

Raising awareness

Solid communications strategies in an area as complex as pharmacovigilance are crucial. A reliable flow of relevant information allows people to stay informed about the benefits and risks of medicines, the importance of reporting adverse drug reactions (ADRs), and the role of dialogues between patients and physicians. 

Uppsala Monitoring Centre strives to meet a global need for better communication practices in our field. Our communications activities focus on raising awareness of UMC’s work, the importance of pharmacovigilance, and the basics of how adverse drug reactions occur and should be handled.

We have also taken on the mission to strengthen communications capacities within the global pharmacovigilance community. We do this through trainings and lectures, social science-based research, and by producing and sharing innovative campaign materials and information packages – much of which you can find on this page.

Uppsala Reports – UMC's magazine

Keep updated on the latest news on safer use of medicines, the activities of the WHO Programme for International Drug Monitoring, and related topics through our magazine, Uppsala Reports.

About & Contact  Subscribe

Read the latest issue  Read all issues

Patient-centred communication materials

UMC has produced a range of materials and campaigns that are aimed directly at the general public and patient populations. We encourage pharmacovigilance actors to use these to spread much-needed information in their own communities. 

Going Further Together

In UMC's documentary “Going further together”,  local pharmacovigilance professionals offer a glimpse into medicines safety issues in Cabo Verde, Morocco, Singapore, Peru, and Croatia. Watch the trailer below, or the full 25-minute documentary on YouTube.

Full documentary

 

Join our community on social media

.